PTC Therapeutics, Inc.
PTCT
$71.70
-$0.27-0.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 3,072.45% | 97.92% | -949.05% | 124.51% | -107.48% |
| Total Depreciation and Amortization | 2.99% | 19.46% | 16.14% | 46.50% | 5.01% |
| Total Amortization of Deferred Charges | 25.90% | -2.56% | 2.62% | 0.99% | 1.00% |
| Total Other Non-Cash Items | -50.52% | 1,165.68% | 58.37% | -156.90% | -59.71% |
| Change in Net Operating Assets | 109.20% | -221.50% | 207.35% | -407.63% | 60.27% |
| Cash from Operations | 318.68% | -72.27% | 48.31% | -13.66% | -106.70% |
| Capital Expenditure | -83.12% | 49.58% | 31.09% | -176.26% | 27.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 100.00% | -200.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -30.07% | -354.35% | 112.71% | 31.97% | -130.26% |
| Cash from Investing | -30.75% | -375.63% | 111.74% | 31.37% | -128.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | 156.08% | -89.76% | 271.38% | 324.89% | -74.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 3,209.04% | -97.88% | 1,887.67% | 284.22% | -57.91% |
| Foreign Exchange rate Adjustments | -66.54% | -115.56% | 261.53% | -144.63% | 151.96% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 245.98% | -147.40% | 189.98% | 25.07% | -166.06% |